125 related articles for article (PubMed ID: 22770609)
1. The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: synthesis, biochemical and biological assessment.
Kantsadi AL; Manta S; Psarra AM; Dimopoulou A; Kiritsis C; Parmenopoulou V; Skamnaki VT; Zoumpoulakis P; Zographos SE; Leonidas DD; Komiotis D
Eur J Med Chem; 2012 Aug; 54():740-9. PubMed ID: 22770609
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
[TBL] [Abstract][Full Text] [Related]
3. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD
Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629
[TBL] [Abstract][Full Text] [Related]
4. Binding of beta-D-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: kinetic and crystallographic studies.
Chrysina ED; Kosmopoulou MN; Kardakaris R; Bischler N; Leonidas DD; Kannan T; Loganathan D; Oikonomakos NG
Bioorg Med Chem; 2005 Feb; 13(3):765-72. PubMed ID: 15653344
[TBL] [Abstract][Full Text] [Related]
5. N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.
Nagy V; Felföldi N; Kónya B; Praly JP; Docsa T; Gergely P; Chrysina ED; Tiraidis C; Kosmopoulou MN; Alexacou KM; Konstantakaki M; Leonidas DD; Zographos SE; Oikonomakos NG; Kozmon S; Tvaroška I; Somsák L
Bioorg Med Chem; 2012 Mar; 20(5):1801-16. PubMed ID: 22325154
[TBL] [Abstract][Full Text] [Related]
6. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
Alexacou KM; Tenchiu Deleanu AC; Chrysina ED; Charavgi MD; Kostas ID; Zographos SE; Oikonomakos NG; Leonidas DD
Bioorg Med Chem; 2010 Nov; 18(22):7911-22. PubMed ID: 20947361
[TBL] [Abstract][Full Text] [Related]
7. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
[TBL] [Abstract][Full Text] [Related]
8. Rapid microwave-enhanced synthesis of C5-alkynyl pyranonucleosides as novel cytotoxic antitumor agents.
Dimopoulou A; Manta S; Kiritsis C; Gkaragkouni DN; Papasotiriou I; Balzarini J; Komiotis D
Bioorg Med Chem Lett; 2013 Mar; 23(5):1330-3. PubMed ID: 23369539
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents.
Zhang L; Jia X; Dong J; Chen D; Liu J; Zhang L; Wen X
Chem Biol Drug Des; 2014 Mar; 83(3):297-305. PubMed ID: 24119242
[TBL] [Abstract][Full Text] [Related]
10. Advances in glycogen phosphorylase inhibitor design.
Oikonomakos NG; Somsák L
Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
[TBL] [Abstract][Full Text] [Related]
11. Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b.
Kyriakis E; Stravodimos GA; Kantsadi AL; Chatzileontiadou DS; Skamnaki VT; Leonidas DD
FEBS Lett; 2015 Jul; 589(15):1787-94. PubMed ID: 25980608
[TBL] [Abstract][Full Text] [Related]
12. 3'-axial CH2 OH substitution on glucopyranose does not increase glycogen phosphorylase inhibitory potency. QM/MM-PBSA calculations suggest why.
Manta S; Xipnitou A; Kiritsis C; Kantsadi AL; Hayes JM; Skamnaki VT; Lamprakis C; Kontou M; Zoumpoulakis P; Zographos SE; Leonidas DD; Komiotis D
Chem Biol Drug Des; 2012 May; 79(5):663-73. PubMed ID: 22296957
[TBL] [Abstract][Full Text] [Related]
13. The σ-hole phenomenon of halogen atoms forms the structural basis of the strong inhibitory potency of C5 halogen substituted glucopyranosyl nucleosides towards glycogen phosphorylase b.
Kantsadi AL; Hayes JM; Manta S; Skamnaki VT; Kiritsis C; Psarra AM; Koutsogiannis Z; Dimopoulou A; Theofanous S; Nikoleousakos N; Zoumpoulakis P; Kontou M; Papadopoulos G; Zographos SE; Komiotis D; Leonidas DD
ChemMedChem; 2012 Apr; 7(4):722-32. PubMed ID: 22267166
[TBL] [Abstract][Full Text] [Related]
14. Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.
Kantsadi AL; Bokor É; Kun S; Stravodimos GA; Chatzileontiadou DSM; Leonidas DD; Juhász-Tóth É; Szakács A; Batta G; Docsa T; Gergely P; Somsák L
Eur J Med Chem; 2016 Nov; 123():737-745. PubMed ID: 27522507
[TBL] [Abstract][Full Text] [Related]
15. Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
Oikonomakos NG; Tiraidis C; Leonidas DD; Zographos SE; Kristiansen M; Jessen CU; Nørskov-Lauritsen L; Agius L
J Med Chem; 2006 Sep; 49(19):5687-701. PubMed ID: 16970395
[TBL] [Abstract][Full Text] [Related]
16. Crystallographic studies on two bioisosteric analogues, N-acetyl-beta-D-glucopyranosylamine and N-trifluoroacetyl-beta-D-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase.
Anagnostou E; Kosmopoulou MN; Chrysina ED; Leonidas DD; Hadjiloi T; Tiraidis C; Zographos SE; Györgydeák Z; Somsák L; Docsa T; Gergely P; Kolisis FN; Oikonomakos NG
Bioorg Med Chem; 2006 Jan; 14(1):181-9. PubMed ID: 16213146
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of N-glucopyranosidic derivatives as potential inhibitors that bind at the catalytic site of glycogen phosphorylase.
Gimisis T
Mini Rev Med Chem; 2010 Oct; 10(12):1127-38. PubMed ID: 20716054
[TBL] [Abstract][Full Text] [Related]
18. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.
Wen X; Sun H; Liu J; Cheng K; Zhang P; Zhang L; Hao J; Zhang L; Ni P; Zographos SE; Leonidas DD; Alexacou KM; Gimisis T; Hayes JM; Oikonomakos NG
J Med Chem; 2008 Jun; 51(12):3540-54. PubMed ID: 18517260
[TBL] [Abstract][Full Text] [Related]
19. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of heterocyclic N-(β-D-glucopyranosyl)carboxamides for inhibition of glycogen phosphorylase.
Kónya B; Docsa T; Gergely P; Somsák L
Carbohydr Res; 2012 Apr; 351():56-63. PubMed ID: 22365837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
